Literature DB >> 7504365

Phosphorylation of the adenovirus DNA-binding protein and epitope mapping of monoclonal antibodies against it.

V Cleghon1, A Piderit, D E Brough, D F Klessig.   

Abstract

To facilitate structure/function studies of the adenovirus type 2 or 5 single-stranded DNA binding protein (DBP), the epitopes of five anti-DBP monoclonal antibodies were mapped. Antibodies 37-3, 38-2, and B6 mapped between DBP residues 131-174 which corresponds to the host-range or hinge region of the molecule. The epitopes for antibodies 16-5 and 18-9 mapped between residues 58-81, and included a phosphorylated serine at position 70. Using antibodies 16-5 or 18-9 as analytical reagents, approximately 1/2 of the DBP molecules present at late times in infected HeLa cells were found to be phosphorylated at serine 70. A similar pattern of serine 70 phosphorylation was observed in productively and abortively infected monkey cells as well as in an E2A-transformed, DBP expressing cell lines. This study also reports the preliminary identification of two new phosphorylation sites on Ad2 DBP at serines 160 and 161 (corresponding to serine 161 on Ad5 DBP). No differences were observed in the phosphorylation of serine 160/161 in DBP isolated from infected HeLa cells or from productively and abortively infected monkey cells. Therefore, phosphorylation of these sites cannot account for the block to wild-type adenovirus growth in monkey cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504365     DOI: 10.1006/viro.1993.1630

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  A comparative analysis of the phosphorylation and biochemical properties of wild type and host range variant DNA binding proteins of human adenovirus 5.

Authors:  E Harfst; K N Leppard
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.

Authors:  Franck Lemiale; Hedi Haddada; Gary J Nabel; Douglas E Brough; C Richter King; Jason G D Gall
Journal:  Vaccine       Date:  2006-11-28       Impact factor: 3.641

3.  Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.

Authors:  Joseph T Bruder; Ping Chen; Elena Semenova; Charlie A Thomas; Svetlana Konovalova; Greg Ekberg; Damodar Ettyreddy; Duncan McVey; Jason G Gall; C Richter King; Douglas E Brough
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

4.  A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.

Authors:  D E Brough; A Lizonova; C Hsu; V A Kulesa; I Kovesdi
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Predicted structure of the adenovirus DNA binding protein.

Authors:  J M Weber; F Cai; J Horvath; J G Guillemette
Journal:  Virus Genes       Date:  1995-01       Impact factor: 2.332

6.  Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28.

Authors:  Christoph A Kahl; Jessica Bonnell; Suja Hiriyanna; Megan Fultz; Cassandra Nyberg-Hoffman; Ping Chen; C Richter King; Jason G D Gall
Journal:  Vaccine       Date:  2010-06-29       Impact factor: 3.641

7.  Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication.

Authors:  P Ward; F B Dean; M E O'Donnell; K I Berns
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes.

Authors:  Jason G D Gall; Alena Lizonova; Damodar EttyReddy; Duncan McVey; Mohammed Zuber; Imre Kovesdi; Barbara Aughtman; C Richter King; Douglas E Brough
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

9.  Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition.

Authors:  Felipe Andrade; Edward Fellows; Dieter E Jenne; Antony Rosen; C S H Young
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

Review 10.  Regulation of human adenovirus alternative RNA splicing by the adenoviral L4-33K and L4-22K proteins.

Authors:  Roberta Biasiotto; Göran Akusjärvi
Journal:  Int J Mol Sci       Date:  2015-01-28       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.